Overview
Minehiko Inomata practices in Toyama, Japan. Inomata is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), IgG4-Related Disease, and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- IgG4-Related DiseaseInomata isAdvanced. Learn about IgG4-Related Disease.
- Lung CancerInomata isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Experienced
- AsthmaInomata isExperienced. Learn about Asthma.
- Lung AdenocarcinomaInomata isExperienced. Learn about Lung Adenocarcinoma.
- Multicentric Reticulohistiocytosis
- Pure Red Cell AplasiaInomata isExperienced. Learn about Pure Red Cell Aplasia.